PKAPX
Price
$14.11
Change
-$0.07 (-0.49%)
Updated
Aug 15 closing price
Net Assets
1.37B
VVIAX
Price
$70.31
Change
-$0.09 (-0.13%)
Updated
Aug 15 closing price
Net Assets
195.81B
Interact to see
Advertisement

PKAPX vs VVIAX

Header iconPKAPX vs VVIAX Comparison
Open Charts PKAPX vs VVIAXBanner chart's image
PIMCO RAE US I-2
Price$14.11
Change-$0.07 (-0.49%)
VolumeN/A
Net Assets1.37B
Vanguard Value Index Adm
Price$70.31
Change-$0.09 (-0.13%)
VolumeN/A
Net Assets195.81B
PKAPX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PKAPX vs. VVIAX commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PKAPX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 196B vs. PKAPX (1.37B). VVIAX pays higher dividends than PKAPX: VVIAX (2.18) vs PKAPX (1.60). PKAPX was incepted earlier than VVIAX: PKAPX (10 years) vs VVIAX (25 years). PKAPX (0.51) is less costly to investors than VVIAX (0.05). PKAPX is a more actively managed with annual turnover of: 73.00 vs. VVIAX (9.00). VVIAX has a lower initial minimum investment than PKAPX: VVIAX (3000) vs PKAPX (1000000). VVIAX annual gain was more profitable for investors over the last year : 7.91 vs. PKAPX (-0.58). VVIAX return over 5 years is better than : 68.54 vs. PKAPX (48.35).
PKAPXVVIAXPKAPX / VVIAX
Total Expense Ratio0.500.051,000%
Annual Report Gross Expense Ratio0.510.051,020%
Fund Existence10 years25 years-
Gain YTD8.2896.517127%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets1.37B196B1%
Annual Yield % from dividends1.602.1873%
Returns for 1 year-0.587.91-7%
Returns for 3 years13.7225.9353%
Returns for 5 years48.3568.5471%
Returns for 10 years72.15114.6163%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EPIX1.930.01
+0.52%
ESSA Pharma
KTTA0.70N/A
N/A
Pasithea Therapeutics Corp
MANH214.79-0.41
-0.19%
Manhattan Associates
NRIM86.31-1.03
-1.18%
Northrim BanCorp
NBTB42.13-0.95
-2.21%
NBT Bancorp